ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1952

Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis

Judith Land1, Lucas L. Lintermans1, Coen A. Stegeman2, Ernesto J. Muñoz-Elías3, Peter Heeringa4, Abraham Rutgers1 and Wayel H. Abdulahad1, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Nephrology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Kineta Inc, Seattle, WA, 4Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ANCA, B cell targeting and B cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Vasculitis - Poster II: ANCA-Associated Vasculitis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Granulomatosis with polyangiitis (GPA) patients are often treated with immunesuppressives or B cell depleting therapy. While B cells are involved in GPA pathogenesis as precursors of anti-neutrophil cytoplasmic antibody (ANCA) producing plasma cells, they can also exert cytokine dependent pro-inflammatory and regulatory functions. In GPA, treatment strategies could be improved by selective targeting of the effector function of B cells. Here, we investigated the effect of the Kv1.3 channel blocker dalazatide (formerly ShK-186) on effector and regulatory B cell function.

Methods: The distribution of B cell subsets was determined in peripheral blood samples of 33 GPA patients and 17 matched healthy controls (HC). Peripheral blood mononuclear cells (PBMC) from GPA patients and HC were stimulated in vitro with CpG-ODN or a combination of CpG, B cell activating factor (BAFF) and interleukin(IL)-21 in the presence and absence of dalazatide. The production levels of total IgG and PR3-ANCA IgG in culture supernatants were analysed by ELISA and Phadia EliA, respectively. In addition, the effect of dalazatide on B cell proliferation and cytokine production was determined by flow cytometry.

Results: Circulating switched and unswitched memory B cells were relatively decreased in GPA patients as compared to HC. Treating stimulated PBMCs with dalazatide resulted in decreased production of both total and PR3-ANCA IgG. Proliferation of B cells was not affected by dalazatide. A strong decrease in production of the pro-inflammatory cytokines TNFα, IL2 and IFNγ was observed with dalazatide treatment. While IL10 production was also decreased with dalazatide treatment in GPA patient samples, this effect was less pronounced. As such, dalazatide modulated the TNFα/IL10 ratio among the B cells, resulting in a relative increase in the regulatory B cell pool.

Conclusion: Dalazatide clearly modulates the effector function of B cells in vitro, by decreasing autoantibody production and the release of pro-inflammatory cytokines. Kv1.3 channel blockade may hold promise as a novel therapeutic strategy in GPA and other B cell mediated autoimmune disorders.


Disclosure: J. Land, None; L. L. Lintermans, None; C. A. Stegeman, None; E. J. Muñoz-Elías, Kineta, Inc, 3; P. Heeringa, None; A. Rutgers, None; W. H. Abdulahad, None.

To cite this abstract in AMA style:

Land J, Lintermans LL, Stegeman CA, Muñoz-Elías EJ, Heeringa P, Rutgers A, Abdulahad WH. Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/kv1-3-channel-blockade-modulates-the-effector-function-of-b-cells-in-granulomatosis-with-polyangiitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/kv1-3-channel-blockade-modulates-the-effector-function-of-b-cells-in-granulomatosis-with-polyangiitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology